<DOC>
	<DOCNO>NCT01230606</DOCNO>
	<brief_summary>This multi-center trial evaluate safety , feasibility , cost effectiveness discharge patient , successful percutaneous coronary intervention ( PCI ) deployment AngiomaxTM closure device , 6 hour 24 hour procedure . Patients randomize 3 ( test ) : 1 ( control ) fashion study population 600 patient 6 investigational site within United States . Patients &lt; 65 year old chosen order stay within low risk group follow 24 hour , 7 day , 30 day via phone office visit . The primary endpoint composite major adverse cardiac cerebral event , incidence major bleed vascular complication . Data acquire study , blind financial information patient satisfaction survey , use order evaluate cost analysis safety procedure .</brief_summary>
	<brief_title>Same Day Versus Next Day Discharge : Ambulatory Closure Device Percutaneous Intervention</brief_title>
	<detailed_description>Closure device relatively new method seal femoral arterial puncture follow procedure include percutaneous intervention ( PCI ) . Because risk severe complication ( e.g. , bleeding , myocardial infarction , stroke , mortality ) associate PCI closure device low , many patient undergo PCI may consider eligible day hospital discharge . As practice ambulatory PCI become common , important evaluate readiness patient under-going PCI same-day discharge anxiety cop ability patient post-discharge . Our hypothesis day discharge patient undergone PCI procedure closure use vascular closure device safe , patient comfortable day discharge process cost efficient current standard stay hospital overnight . The current pilot study multi-center , randomize parallel arm , control trial low-risk patient undergo elective PCI procedure . Overall , 600 patient enrol . After provide informed consent , participant randomize leave hospital day PCI procedure stay overnight 1:1 ratio . Data collection include self-administered questionnaire hospital discharge , telephone interview 7-days 30-days post-hospital discharge , chart abstraction . The primary outcome study difference across randomization arm patient satisfaction score validate 10-item Post-discharge cop difficulty scale assess 7 day post-discharge . Secondary outcome include difference across randomization group symptom anxiety , readiness hospital discharge , patient satisfaction time discharge , post-procedure pain soreness , cost-savings . While data safety monitor board track adverse event ( i.e. , myocardial infarction , hematoma , hospitalization , mortality ) , anticipate event occur make meaningful inference beyond PCI safe regardless time hospital discharge . The data pilot study determine comfort patient experience undergoing PCI ambulatory ( i.e , same-day ) hospital discharge . Furthermore , pilot study provide foundation large scale non-inferiority study same-day discharge outcome include myocardial infarction , bleeding , mortality . Such data indicate overall feasibility early ambulatory PCI potential radically alter health care delivery follow PCI .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>. &lt; 75 year age time procedure . 2 . Patient type A B lesion ( ) 3 . Femoral access site amenable closure vascular closure device . 4 . Over 2 hour since completion PCI procedure ( least 2 hour must elapse completion PCI subject become eligible ) . 1 . Patient life expectancy le 12 month . 2 . Patient recent evidence acute coronary syndrome ( MI ) 3 . Femoral access difficult site amenable closure device 4 . Anticoagulants unfractionated heparin bivalirudin use procedure ( i.e . enoxaparin ) . 5 . Patient sub optimal angiographic outcome clinical complication ( ) PCI 6 . The PCI occur something native coronary artery 7 . Angiographic evidence thrombus 8 . Patient 3 stent implant PCI 9 . Patient INR &gt; 2 , Platelet count &lt; 100,000 Hematocrit &lt; 25 10 . Occlusion major side branch PCI &gt; 1.5mm 11 . Patient ejection fraction ≤30 % 12 . Known allergy PCI procedural medication 13 . Patient report live 30 minute hospital ambulance . 14 . Patient provide informed consent agree followup schedule . 15 . Evidence vascular complication ( ) ( e.g . dissection , hematoma , bleed ) periprocedure 16 . Patient pregnant 17 . Evidence infection ( e.g . fever , pu , swell ) periprocedure 18 . Patients chronic renal insufficiency ( e.g . serum creatinine ≥1.5 mg/dL )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Percutaneous Intervention</keyword>
	<keyword>Percutaneous Coronary Intervention</keyword>
	<keyword>Catheterization</keyword>
	<keyword>Coronary Catheterization</keyword>
	<keyword>Same day Discharge</keyword>
	<keyword>Next Day Discharge</keyword>
	<keyword>Patient Satisfaction</keyword>
	<keyword>Multi-Center</keyword>
	<keyword>Randomized</keyword>
	<keyword>Low-risk PCI</keyword>
	<keyword>BlindedClosure device</keyword>
	<keyword>Vascular closure device</keyword>
</DOC>